Search Results 1-10 of 16975 for intestinal metaplasia
Mayo Clinic researchers have previously demonstrated that both ER approaches yield comparable rates of complete remission of intestinal metaplasia (CRIM).
Gastrointestinal stromal tumors (GISTs); Gastric intestinal metaplasia; Lymphoma of colon or rectum; Melanoma of the GI tract; Uncommon neoplasms of the stomach ...
Intestinal metaplasia. In this condition, cells in the stomach lining change ... These include hereditary diffuse gastric cancer, gastric adenocarcinoma and ...
In this digestive condition, the esophagus becomes damaged by repeated exposure to stomach acids. Learn about treatments to improve symptoms and lower ...
Examining the impact of endoscopic resection approach on intestinal metaplasia and dysplasia recurrence after complete remission: EMR versus ESD. Endoscopic ...
That means the normal cells of the esophagus, called “squamous cells,” are replaced by intestinal cells. “Metaplasia” means the replacement of one cell by ...
This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...
... intestinal metaplasia (CRIM). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.